Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)

by Moehler Markus, Dufour Patrick, Bachellier Phillippe, Raoul Jean-Luc, Delpero Jean-Robert, Laurent Stéphanie, Berrevoet Frederik, Lesurtel Mickael, Pestalozzi Bernhard, Heinrich Stefan, Weber Achim, Lang Hauke, Rogiers Xavier, Clavien Pierre-Alain
Published 2011-08-01

A polymorphism of <it>EGFR </it>extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment

by Monges Geneviève, Ayadi Mounay, Lagarde Arnaud, Taylor-Smedra Brynn, Esteyries Séverine, Gonçalves Anthony, Bertucci François, Esterni Benjamin, Delpero Jean-Robert, Turrini Olivier, Lelong Bernard, Viens Patrice, Borg Jean-Paul, Birnbaum Daniel, Olschwang Sylviane, Viret Frédéric
Published 2008-06-01